[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-358891-105":59,"doc-detail-358891-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","predicting-optimal-impact-interventions-in-the-post-hpv-vaccination-world","Predicting optimal impact interventions in the post-HPV vaccination world","","Prophylactic HPV vaccination reshapes exposure to preventable infections and reduces related morbidity. The review examines how pneumococcal and HPV vaccination influence population biology, focusing on HPV type-replacement after near elimination of vaccine-covered types and how remaining types affect cervical cancer risk. It synthesizes results from European, country-specific modeling of cervical screening choices for vaccinated and unvaccinated women under varying coverage and strategies. Optimal screening balance depends on cancer risks across differently vaccinated birth cohorts.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/predicting-optimal-impact-interventions-in-the-post-hpv-vaccination-world/358891/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/predicting-optimal-impact-interventions-in-the-post-hpv-vaccination-world/358891.png","ImageObject",300,407,{"name":92,"@type":93},"Riley","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What does the review focus on regarding HPV vaccination’s effects?","Question",{"text":113,"@type":114},"It focuses on how prophylactic HPV vaccination changes exposure, affects population biology, and influences public health outcomes through HPV type-replacement and screening implications.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How is HPV type-replacement described after vaccination?",{"text":118,"@type":114},"It discusses data from communities where vaccine-covered HPV types are almost eliminated, reviewing replacement and interactions among remaining HPV types that influence cervical cancer risk.",{"name":120,"@type":111,"acceptedAnswer":121},"Why is risk-based cervical screening important after HPV vaccination?",{"text":122,"@type":114},"Because rapid changes in HPV prevalence and disease risk make it difficult to design optimal strategies, and an appropriate benefit–harm balance requires understanding cancer risks across differently vaccinated birth cohorts.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},358891,1790211052,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374391975076,"https://ap-avatar.wpscdn.com/avatar/14000253ca4ec9f6853?x-image-process=image/resize,m_fixed,w_180,h_180&k=1783305029341752051","DOI: 10.1002/ijc.70297  \nREVIE W  \nPredicting optimal impact interventions in the postHPV vaccination world  \nMatti Lehtinen 1,2  | Marc Lipsitch 3  | Ville N. Pimenoff 2  | Karin Sundström 1  | Johannes Berkhof 4  | Iacopo Baussano 5 | Simopekka Vänskä 6  | Joakim Dillner 1   \n1Centre for Cervical Cancer Elimination, Department of Clinical Science, Intervention and Technology, Karolinska Institute, Stockholm, Sweden  \n2Research Unit of Population Health, Faculty of Medicine, Oulu University, Oulu, Finland 3Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, USA  \n4Department of Epidemiology and Data Science, Amsterdam University Medical Centers, Location VUMC, Amsterdam, The Netherlands  \n5Early detection, Prevention and Infections Branch, International Agency for Research on Cancer, Lyon, France  \n6Infectious Disease Control & Vaccinations, Finnish Institute for Health & Welfare, National Institute for Health & Welfare, Helsinki, Finland  \nCorrespondence  \nMatti Lehtinen, Center for Cervical Cancer Elimination, Karolinska Institute,  \nS 177 17, Stockholm, Sweden.  \n[Email:](Email: matti.lehtinen@ki.se)[ matti.lehtinen@ki.se](Email: matti.lehtinen@ki.se); matti.antero. [lehtinen@gmail.com](lehtinen@gmail.com)  \n[Correction added on13February2026, after first online publication: The copyright line was changed].  \nAbstract  \nProphylactic vaccination is a powerful tool that changes exposure to infections and associated morbidity of preventable diseases. We discuss the impact of pneumococci and human papillomavirus (HPV) vaccination on the population biology of the two micro-organisms and related public health effects. Data on HPV type-replacement in communities where vaccine-covered HPVs are almost eliminated, and interactions of the remaining HPV types on the risk of cervical cancer are reviewed. Results of comprehensive models for European country-specific conduction of cervical screening among HPV-vaccinated and unvaccinated women, assuming different HPV-vaccination coverage and strategies, are discussed in our policy-oriented review. An acceptable balance of benefits and harms of cervical cancer screening in HPV vaccinated populations requires an understanding of cancer risks in differently vaccinated birth cohorts. Finally, the challenges are complex but can be met if strategies are applied that (i) as fast as possible achieve herd effect and (ii) use a risk-based design of HPV screening.  \nKEYWOR DS  \ncervical cancer, human papillomavirus, screening, type-replacement, vaccination  \n1 | INTRODUCTION  \nProphylactic human papillomavirus (HPV) vaccination is a powerful tool that changes exposure to HPV infections and the risk of HPVassociated cancer morbidity. It also impacts the fundamental basis of how to perform optimal cervical screening.  \nAbbreviations: CIS, cervical carcinoma in situ; DALY, disability-adjusted-life-years; EGW, external genital warts; IPD, invasive pneumococcal disease; LRCC, lifetime risk of cervical cancer; SCC, squamous cervical cancer; WHO, World Health Organization.  \nWe have previously reviewed the scientific approaches that could be used to achieve the WHO call for action to globally eliminate cervical cancer, which is threatened by low compliance. 1,2 For example, gender-neutral HPV vaccination is particularly effective in achieving fast herd immunity, even with moderate vaccination coverage.3–6 Herd effect, that is, protection of unvaccinated (including marginalized) women and men in contact with vaccinated individuals takes place even with a lower than the desired HPV vaccination or screening coverage. 1,7 Finally, vaccination can also be used to increase the efficiency of screening.8,9  \nThis is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or ","cbCaibunLtEi82Y1","https://ap.wps.com/l/cbCaibunLtEi82Y1","pdf",1785363,"English","# Abstract\n## Introduction\n## Herd effect and screening optimization\n## Microbial population biology and type-replacement","[{\"question\":\"What does the review focus on regarding HPV vaccination’s effects?\",\"answer\":\"It focuses on how prophylactic HPV vaccination changes exposure, affects population biology, and influences public health outcomes through HPV type-replacement and screening implications.\"},{\"question\":\"How is HPV type-replacement described after vaccination?\",\"answer\":\"It discusses data from communities where vaccine-covered HPV types are almost eliminated, reviewing replacement and interactions among remaining HPV types that influence cervical cancer risk.\"},{\"question\":\"Why is risk-based cervical screening important after HPV vaccination?\",\"answer\":\"Because rapid changes in HPV prevalence and disease risk make it difficult to design optimal strategies, and an appropriate benefit–harm balance requires understanding cancer risks across differently vaccinated birth cohorts.\"}]","Predicting optimal impact interventions in the post-HPV vaccination world | PDF",1790135568,25,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/284dc3fd7c11ee1868a30b6e7b15f5ac.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7a4199d9ddfd75543400fa7a17324ef3.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6f16f5cc81544435b46da56248c61db7.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e3fec3792839142452a5d871b98a0b5e.webp",980,1287]